ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)
China
· Delayed Price · Currency is CNY 12.19
-0.36 (-2.87%)
Mar 11, 2026, 3:04 PM CST
SHE:300254 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,214 | 2,173 | 2,327 | 1,636 | 1,981 | 1,571 | Upgrade
|
| Market Cap Growth | 41.31% | -6.62% | 42.24% | -17.43% | 26.13% | -7.02% | Upgrade
|
| Enterprise Value | 3,894 | 2,352 | 2,579 | 1,773 | 2,248 | 1,769 | Upgrade
|
| Last Close Price | 12.55 | 8.75 | 9.63 | 6.77 | 8.69 | 6.89 | Upgrade
|
| PE Ratio | 150.38 | 51.50 | 92.35 | - | - | - | Upgrade
|
| Forward PE | - | 47.48 | 47.48 | 47.48 | 47.48 | 47.48 | Upgrade
|
| PS Ratio | 3.78 | 2.57 | 2.91 | 1.97 | 2.13 | 1.85 | Upgrade
|
| PB Ratio | 5.57 | 3.63 | 2.99 | 2.24 | 2.66 | 1.80 | Upgrade
|
| P/TBV Ratio | - | - | 25.93 | 32.48 | 68.49 | 21.65 | Upgrade
|
| P/FCF Ratio | 50.06 | 111.77 | 596.91 | 34.01 | 33.02 | - | Upgrade
|
| P/OCF Ratio | 38.59 | 30.63 | 61.53 | 21.85 | 20.44 | - | Upgrade
|
| EV/Sales Ratio | 4.59 | 2.78 | 3.23 | 2.14 | 2.42 | 2.09 | Upgrade
|
| EV/EBITDA Ratio | 29.57 | 20.66 | 33.20 | 51.17 | 63.24 | - | Upgrade
|
| EV/EBIT Ratio | 51.67 | 37.35 | 102.75 | - | - | - | Upgrade
|
| EV/FCF Ratio | 60.66 | 120.98 | 661.62 | 36.87 | 37.47 | - | Upgrade
|
| Debt / Equity Ratio | 0.91 | 0.52 | 0.29 | 0.40 | 0.31 | 0.35 | Upgrade
|
| Debt / EBITDA Ratio | 4.00 | 2.58 | 2.71 | 7.02 | 5.92 | - | Upgrade
|
| Debt / FCF Ratio | 8.20 | 16.03 | 58.03 | 6.01 | 3.83 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.69 | 0.27 | 0.12 | 0.03 | 0.16 | 0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.18 | 1.42 | 1.21 | 0.72 | 3.44 | -0.88 | Upgrade
|
| Net Debt / FCF Ratio | 6.19 | 8.34 | 24.17 | 0.52 | 2.04 | -2.24 | Upgrade
|
| Asset Turnover | 0.55 | 0.57 | 0.53 | 0.53 | 0.56 | 0.47 | Upgrade
|
| Inventory Turnover | 2.22 | 2.23 | 2.32 | 2.37 | 2.51 | 2.09 | Upgrade
|
| Quick Ratio | 0.62 | 0.60 | 0.63 | 0.63 | 0.63 | 0.87 | Upgrade
|
| Current Ratio | 0.92 | 0.88 | 0.96 | 0.85 | 0.94 | 1.18 | Upgrade
|
| Return on Equity (ROE) | 7.85% | 10.86% | 6.46% | -13.28% | -9.22% | -31.08% | Upgrade
|
| Return on Assets (ROA) | 3.06% | 2.64% | 1.04% | -0.95% | -1.06% | -6.88% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.32% | 7.15% | 2.72% | -2.92% | -3.03% | -18.65% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.70% | 6.40% | 2.50% | -2.40% | -2.50% | -15.10% | Upgrade
|
| Earnings Yield | 0.63% | 1.94% | 1.08% | -7.25% | -4.62% | -16.70% | Upgrade
|
| FCF Yield | 2.00% | 0.90% | 0.17% | 2.94% | 3.03% | -3.33% | Upgrade
|
| Payout Ratio | 90.75% | 29.20% | 52.84% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.95% | -0.20% | -1.89% | -4.00% | -6.92% | -2.25% | Upgrade
|
| Total Shareholder Return | -0.95% | -0.20% | -1.89% | -4.00% | -6.92% | -2.25% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.